<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fatty acid patterns of plasma and platelet <z:chebi fb="23" ids="18059">lipids</z:chebi>, platelet aggregation and <z:chebi fb="0" ids="15627">thromboxane A2</z:chebi> (TxA2) production were studied in young patients (n = 12) with <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> and in healthy controls (n = 13) </plain></SENT>
<SENT sid="1" pm="."><plain>Platelet <z:chebi fb="0" ids="15843">arachidonic acid</z:chebi> content was significantly reduced in the <z:hpo ids='HP_0001297'>stroke</z:hpo> patients, but in vitro platelet aggregation was similar in the two groups </plain></SENT>
<SENT sid="2" pm="."><plain>A low dose of acetosalicylic acid (<z:chebi fb="37" ids="15365">ASA</z:chebi>) (100 mg) suppressed <z:chebi fb="0" ids="26995">thromboxane</z:chebi> production and normalized the platelet <z:chebi fb="0" ids="15843">arachidonic acid</z:chebi> values </plain></SENT>
<SENT sid="3" pm="."><plain>The low <z:chebi fb="0" ids="15843">arachidonic acid</z:chebi> in platelets is probably due to its increased consumption, indicating platelet activation in vivo </plain></SENT>
</text></document>